Kezar Life Sciences, Inc.

Recent News View All News

Kezar Life Sciences to Participate in Two Upcoming Investor Conferences

Sep 2, 2021 7:00am EDT

Kezar Life Sciences Announces Completion of Enrollment of Its Phase 2 PRESIDIO Clinical Trial of KZR-616 in Polymyositis and Dermatomyositis

Aug 23, 2021 7:01am EDT

Recent Events View IR Calendar

H. C. Wainwright 23rd Annual Global Investment Conference

Sep 13, 2021 7:00 am EDT

Wells Fargo Virtual Healthcare Conference

Sep 9, 2021 4:00 pm EDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings